Progyny Inc. (PGNY) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Progyny Inc. (PGNY)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

20.08

-0.22 (-1.08%)

At close: Jan 14, 2025, 3:59 PM

19.85

-1.13%

After-hours Jan 14, 2025, 06:25 PM EST

undefined% (undefined)

Bid	18.35
Market Cap	1.71B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.6
PE Ratio (ttm)	33.46
Forward PE	n/a
Analyst	Hold

Ask	20.9
Volume	2,002,976
Avg. Volume (20D)	1,776,409
Open	20.41
Previous Close	20.30
Day's Range	20.00 - 20.73
52-Week Range	13.39 - 42.08
Beta	undefined

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the me...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Oct 25, 2019

Employees 563

Stock Exchange NASDAQ

Ticker Symbol PGNY

Website https://www.progyny.com

Analyst Forecast

According to 11 analyst ratings, the average rating for PGNY stock is "Hold." The 12-month stock price forecast is $20, which is a decrease of -0.39% from the latest price.

Buy 18.18%

Hold 63.64%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Progyny Inc. is scheduled to release its earnings on Feb 25, 2025, during market hours.
Analysts project revenue of $275.01M, reflecting a 1.88% YoY growth and earnings per share of 0.36, making a 176.92% increase YoY.

Why Price Moved

2 months ago · Source

-19.09%

Progyny share shares are trading lower after the c... Unlock content with Pro Subscription

3 months ago · Source

-32.65%

Progyny shares are trading lower after a client elected to exercise an option to terminate its services agreement with the company.

News

2 weeks ago · seekingalpha.com

The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying

Progyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with...

1 month ago · seekingalpha.com

Progyny: Rating Downgrade On Uncertain Growth Outlook

I recommend downgrading Progyny from buy to hold due to a loss of confidence in its growth outlook and increased uncertainty. PGNY's Q3 2024 results were disappointing, with revenue and margins fallin...

1 month ago · seekingalpha.com

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

I initially rated Progyny a "Buy" in late 2022, but 2024 has been disastrous, with a 60% stock drop and loss of Amazon as a client. Q3 2024 financials show minimal revenue growth, declining margins, a...

2 months ago · fool.com

Why Progyny Stock Crashed Today

2 months ago · benzinga.com

These Analysts Slash Their Forecasts On Progyny Following Q3 Results

Progyny, Inc. PGNY reported worse-than-expected third-quarter sales results and issued FY24 revenue guidance below estimates.

2 months ago · seekingalpha.com

Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript

Progyny, Inc (NASDAQ:PGNY ) Q3 2024 Earnings Conference Call November 12, 2024 4:45 PM ET Company Participants James Hart - Investor Relations Peter Anevski - CEO Michael Sturmer - President Mark Livi...

2 months ago · zacks.com

Progyny (PGNY) Tops Q3 Earnings Estimates

Progyny (PGNY) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.16 per share a year ago.

3 months ago · seekingalpha.com

Progyny: Poor Year Raises Concerns For Future (Downgrade)

Progyny has had a rough start to the year, with the share price declining by double digits in response to both Q1'24 and Q2'24. In September, they filed an 8-K informing investors that they lost their...